Geneos Wealth Management’s Usana Health Sciences USNA Stock Holding History

Geneos Wealth Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-850	Closed	-$63K	–	2577
2022 Q2	$63K	Hold	850	–	–	﹤0.01%	1184
2022 Q1	$67K	Hold	850	–	–	﹤0.01%	1243
2021 Q4	$86K	Hold	850	–	–	﹤0.01%	1231
2021 Q3	$79K	Hold	850	–	–	﹤0.01%	1265
2021 Q2	$86K	Hold	850	–	–	﹤0.01%	1223
2021 Q1	$76K	Hold	850	–	–	﹤0.01%	1418
2020 Q4	$83K	Hold	850	–	–	﹤0.01%	1213
2020 Q3	$63K	Hold	850	–	–	﹤0.01%	1149
2020 Q2	$58K	Hold	850	–	–	﹤0.01%	1155
2020 Q1	$50K	Hold	850	–	–	﹤0.01%	1113
2019 Q4	$68K	Hold	850	–	–	﹤0.01%	1108
2019 Q3	$58K	Hold	850	–	–	﹤0.01%	1114
2019 Q2	$67K	Hold	850	–	–	﹤0.01%	1064
2019 Q1	$71K	Hold	850	–	–	﹤0.01%	994
2018 Q4	$97K	Hold	850	–	–	0.01%	844
2018 Q3	$102K	Hold	850	–	–	0.01%	875
2018 Q2	$98K	Hold	850	–	–	0.01%	792
2018 Q1	$73K	Hold	850	–	–	0.01%	855
2017 Q4	$62K	Hold	850	–	–	0.01%	922
2017 Q3	$49K	Hold	850	–	–	﹤0.01%	957
2017 Q2	$54K	Hold	850	–	–	0.01%	894
2017 Q1	$48K	Hold	850	–	–	0.01%	902
2016 Q4	$52K	Hold	850	–	–	0.01%	827
2016 Q3	$58K	Hold	850	–	–	0.01%	763
2016 Q2	$47K	Hold	850	–	–	0.01%	830
2016 Q1	$51K	Buy	+850	New	+$50K	0.01%	797

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geneos Wealth Management's USNA Position: Q3 2022 in Review

Geneos Wealth Management sold out of Usana Health Sciences (USNA) in Q3 2022, closing a stake of 850 shares — an estimated $63K sold.

Geneos Wealth Management first reported a position in USNA in Q1 2016 and held it in 26 quarters. The position peaked at $102K in Q3 2018. 172 funds tracked by Wall St. Rank hold USNA as of Q3 2022.

Geneos Wealth Management reported no remaining Usana Health Sciences position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 850 Usana Health Sciences shares in Q3 2022, an estimated $63K.
Geneos Wealth Management first reported a position in Usana Health Sciences in Q1 2016 and held it in 26 quarters.
Geneos Wealth Management's Usana Health Sciences position peaked at $102K in Q3 2018.
172 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.